Company / Tangible Book Value per Share
Charles River Laboratories Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$8.13
FY2025
5-year range
-$3.56 / $11.98
FY2021-FY2025
Trend
-32.1%
vs FY2024
Sector context
#56 of 159
Health Care
What the data says
At $8.13, Charles River Laboratories's tangible book value per share ranks #56 of 159 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-3.56 in FY2021 to $11.98 in FY2024.
Based on SEC 10-K filings.
8.13 in FY2025 with a 5-year CAGR of -7.1%.
Declined from $9.85 to $8.13 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +48.1%
- 5-Year CAGR
- -7.1%
- 10-Year CAGR
- -
Sector benchmark
-56.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 32.1% year-over-year.
- Ranks #56 out of 159 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.13 | -32.1% |
| FY2024 | $11.98 | +21.6% |
| FY2023 | $9.85 | +293.4% |
| FY2022 | $2.50 | +170.4% |
| FY2021 | -$3.56 | -130.3% |
| FY2020 | $11.73 | +46.0% |
| FY2019 | $8.04 | +442.7% |
| FY2018 | $1.48 | -70.8% |
| FY2017 | $5.07 | +380.8% |
| FY2016 | $1.05 | -87.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026